Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Scientists Say Plan B Decision-Makers At CDER “Should Be Removed”
02 Apr 2009
•
By
Dan Schiff
Sen. Grassley releases letter and urges FDA to improve the climate for whistleblowers.
More from Archive
More from Pink Sheet